Html code here! Replace this with any non empty raw html code and that's it.

Study examines cancer risk patterns in people with type 1 diabetes

Date:

Share this article:

Del denne artikel:

A new analysis suggests that people with type 1 diabetes may face a higher bladder cancer risk than previously understood.

Many people living with a long-term health condition know the uneasy balance between daily routines and the constant need to monitor their bodies.

When you’re managing something as demanding as type 1 diabetes, you quickly learn how every decision feels connected to your future health—and how new research can offer both reassurance and new concerns.

A deeper look at an overlooked risk

For years, the conversation around diabetes and cancer has mostly focused on type 2 diabetes.

But new work from researchers at the Keck School of Medicine of USC suggests that people with type 1 diabetes may face a far higher risk of developing bladder cancer than anyone previously realized.

Also read: Three everyday ingredients may help ease inflammation

Their analysis re-examined older studies through a new lens, correcting a flaw that had distorted the data for decades: the impact of smoking.

Older datasets rarely included reliable information on tobacco use, even though smoking is the leading known cause of bladder cancer.

By reconstructing smoking patterns using global health sources—including WHO data—the team uncovered a much clearer picture.

What the new analysis suggests

Once the influence of smoking was separated from other factors, researchers found that people with type 1 diabetes were more likely to develop bladder cancer than the general population.

Also read: How almonds influence blood sugar in everyday eating

The team believes several biological pathways linked to lifelong autoimmune diabetes may contribute, though these mechanisms are still being explored.

Their findings highlight three emerging points:

• Managing blood sugar may play a larger role in cancer prevention than previously understood
• Smoking avoidance could be especially critical for people with type 1 diabetes
• Current cancer-risk guidelines may need updating to reflect this hidden association

Looking ahead

The researchers are now analyzing nearly 100 studies on type 2 diabetes to understand how metabolic conditions and their treatments may influence cancer development.

Also read: Strawberries may hold the key to a better blood sugar balance

Their work could eventually shape new screening strategies and help patients make better-informed health decisions.

The article is based on information from News Medical and Diabetes Research

Also read: Study reveals kidney disease now among top global causes of death

Other articles

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.

New analysis: Six out of ten women may be overweight in 2050

Developments in women’s health point in a worrying direction. Cardiovascular diseases in particular may become more prevalent in the future.

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.